Phase I clinical trial: T‐cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA‐A0201‐specific peptides from prostate‐specific membrane antigen
- 7 December 1996
- journal article
- Published by Wiley in The Prostate
- Vol. 29 (6), 371-380
- https://doi.org/10.1002/(sici)1097-0045(199612)29:6<371::aid-pros5>3.3.co;2-3